Recent Price Performance and Benchmark Comparison
Beta Drugs Ltd’s recent price trajectory has been disappointing when compared to the broader market. Over the past week, the stock declined by 1.18%, whereas the Sensex gained 0.26%. This underperformance extends over longer periods as well, with the stock falling 3.63% in the last month while the Sensex rose by 0.45%. Year-to-date figures reveal a more pronounced divergence: Beta Drugs Ltd has lost 15.88% of its value, contrasting sharply with the Sensex’s 10.08% gain. Over the last year, the stock’s decline deepened to 22.16%, while the benchmark index advanced by 5.08%. Despite these recent setbacks, the stock’s longer-term performance remains robust, having delivered a 141.77% return over three years and an impressive 1,42...
Read More





